Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tapio Nousiainen

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|April 21, 2006
[The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease]Esa Jantunen, Karri Penttilä, Taru Kuittinen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|September 17, 2002
[Large granular lymphocytic leukemia]Esa Jantunen, Eija Mahlamäki, Esa Hämäläinen, et al.
Transfusion|February 7, 2012
Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factorVille Varmavuo, Pentti Mäntymaa, Taru Kuittinen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|November 23, 2005
[Gaucher disease]Timo Timonen, Merja Möttönen, Tapio Nousiainen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 31, 2003
Colonization of hospital water systems by legionellae, mycobacteria and other heterotrophic bacteria potentially hazardous to risk group patientsJaana Kusnetsov, Eila Torvinen, Outi Perola, et al.
European Journal of Haematology|January 5, 2011
Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experienceEsa Jantunen, Taru Kuittinen, Eija Mahlamäki, et al.
Clinical Physiology and Functional Imaging|February 6, 2010
Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphomaTaru Kuittinen, Esa Jantunen, Esko Vanninen, et al.
European Journal of Haematology|April 28, 2012
Blood graft composition after plerixafor injection in patients with NHLVille Varmavuo, Pentti Mäntymaa, Tapio Nousiainen, et al.
Transfusion|August 18, 2012
CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patientsVille Varmavuo, Pentti Mäntymaa, Raija Silvennoinen, et al.
Clinical Therapeutics|March 31, 2012
Economic evaluation of sequential treatments for follicular non-hodgkin lymphomaErkki J Soini, Janne A Martikainen, Ville Vihervaara, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Duodecim; Laaketieteellinen Aikakauskirja|April 21, 2006
[The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease]Esa Jantunen, Karri Penttilä, Taru Kuittinen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|September 17, 2002
[Large granular lymphocytic leukemia]Esa Jantunen, Eija Mahlamäki, Esa Hämäläinen, et al.
Transfusion|February 7, 2012
Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factorVille Varmavuo, Pentti Mäntymaa, Taru Kuittinen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|November 23, 2005
[Gaucher disease]Timo Timonen, Merja Möttönen, Tapio Nousiainen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 31, 2003
Colonization of hospital water systems by legionellae, mycobacteria and other heterotrophic bacteria potentially hazardous to risk group patientsJaana Kusnetsov, Eila Torvinen, Outi Perola, et al.
European Journal of Haematology|January 5, 2011
Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experienceEsa Jantunen, Taru Kuittinen, Eija Mahlamäki, et al.
Clinical Physiology and Functional Imaging|February 6, 2010
Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphomaTaru Kuittinen, Esa Jantunen, Esko Vanninen, et al.
European Journal of Haematology|April 28, 2012
Blood graft composition after plerixafor injection in patients with NHLVille Varmavuo, Pentti Mäntymaa, Tapio Nousiainen, et al.
Transfusion|August 18, 2012
CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patientsVille Varmavuo, Pentti Mäntymaa, Raija Silvennoinen, et al.
Clinical Therapeutics|March 31, 2012
Economic evaluation of sequential treatments for follicular non-hodgkin lymphomaErkki J Soini, Janne A Martikainen, Ville Vihervaara, et al.
Pageof 4